See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100397_2018_Ayala_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001100397, Ayala Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 81,242,824 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,856,775 |
| 2 | PropertyPlantAndEquipmentNet | 7,111,081 |
| 3 | remainder_Assets | 431,098 |
| 4 | LiabilitiesCurrent | 20,864,298 |
| 5 | LiabilitiesNoncurrent | 1,038,555 |
| 6 | remainder_Liabilities | 17,478,758 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 36,604,182 |
| 9 | ResearchAndDevelopmentExpense | 71,486,793 |
| 10 | remainder_Expenses | -3,933,510 |
| 11 | remainder_Revenues | 52,087,282 |
| 12 | remainder_NetIncome | 624,618 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 93,641,778 |
| 1 | Liabilities | 39,381,611 |
| 2 | Expenses | 104,157,465 |
| 3 | Revenues | 52,087,282 |
| 4 | StockholdersEquity | 54,260,167 |
| 5 | NetIncome | -51,445,565 |
| 6 | ComprehensiveNetIncome | -51,445,565 |
| 7 | BaseVar | 144,946,377 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.00 |
| 9 | EconomicCapitalRatio | 2.31 |
Edgar->Model Mapping
Feature Distribution
Change over Time
